Enbrel Liquid Immunogenicity Protocol

NCT00249041 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: 50 mg Etanercept
DRUG: Enbrel liquid

Sponsor

Amgen

Collaborators

[object Object]